Long-Term and Sustained Therapeutic Results of a Specific Promonocyte Cell Formulation in Refractory Angina: ReACT® (Refractory Angina Cell Therapy) Clinical Update and Cost-Effective Analysis

Cell Transplantation

Volumn 24, Issue 6, 2015, Pages 955-970

  Hossne, Nelson Americo ^a   Cruz, Eduardo ^b,c   Buffolo, Enio ^a   Coimbra, Anna Carolina Teixeira de Siqueira Mac Dowell ^b,c   Machado, Janaina ^b   Goldenberg, Regina Coeli Dos Santos ^d   Regazzi, Germana ^b,c   Azevedo, Silvia ^b   Invitti, Adriana Luckow ^b,c   Branco, João Nelson Rodrigues ^a   de Oliveira, José Salvador Rodrigues ^a   Stolf, Noedir Antonio Groppo ^e   Miller, Leslie W ^f   Sanberg, Paul R ^f,g  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto de Biologia   (Brazil)

^c Polo de Biotecnologia do Rio de Janeiro Cidade Universitária   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Angiogenesis; Bone marrow mononuclear cells; Promonocyte; Refractory angina; Refractory angina cell therapy

Indexed keywords

AGED; ANGINA PECTORIS; CARDIAC MUSCLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MONOCYTE MACROPHAGE PRECURSOR CELL; MYOCARDIAL ISCHEMIA; NONPARAMETRIC TEST; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; QUESTIONNAIRE; SCINTISCANNING; TIME FACTOR; TRANSPLANTATION;

AGED; ANGINA PECTORIS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MONOCYTE-MACROPHAGE PRECURSOR CELLS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84991220076     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X681595     Document Type: Article

References (33)

1. Beeres, S. L.; Bax, J. J.; Dibbets-Schneider, P.; Stokkel, M. P.; Fibbe, W. E.; van der Wall, E. E.; Schalij, M. J.; Atsma, D. E. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelvemonth follow-up results. Am. Heart J. 152:684.e11–16; 2006.
2. Beeres, S. L.; Bax, J. J.; Kaandorp, T. A.; Zeppenfeld, K.; Lamb, H. J.; Dibbets-Schneider, P.; Stokkel, M. P.; Fibbe, W. E.; de Roos, A.; van der Wall, E. E.; Schalij, M. J.; Atsma, D. E. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. Am. J. Cardiol. 97:1326–1331; 2006.
3. Bouchentouf, M.; Paradis, P.; Forner, K.; Cuerquis, J.; Boivin, M.-N.; Jiamin, Z.; Boulassel, M. R.; Routy, J. P.; Schiffrin, E. L.; Galipeau, J. Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant. 19(4):359–368; 2010.
4. Briguori, C.; Reimers, B.; Sarais, C.; Napodano, M.; Pascotto, P.; Azzarello, G.; Bregni, M.; Porcellini, A.; Vinante, O.; Zanco, P.; Peschle, C.; Condorelli, G.; Colombo, A. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am. Heart J. 151:674–680; 2006.
5. Charwat, S.; Gyöngyösi, M.; Lang, I.; Graf, S.; Beran, G.; Hemetsberger, R.; Nyolczas, N.; Sochor, H.; Glogar, D. Role of adult bone marrow stem cells in the repair of ischemic myocardium: Current state of the art. Exp. Hematol. 36:672–680; 2008.
6. Hale, S. L.; Dai, W.; Dow, J. S.; Kloner, R. A mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessment. Life Sci. 83:511–515; 2008.
7. Hashemi, S. M.; Ghods, S.; Kolodgie, F. D.; Parcham-Azad, K.; Keane, M.; Hamamdzic, D.; Young, R.; Rippy, M. K.; Virmani, R.; Litt, H.; Wilensky, R. L. A placebo controlled dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur. Heart J. 29:251–259; 2008.
8. Henning, R. J.; Burgos, J. D.; Vasko, M.; Alvarado, F.; Sanberg, C. D.; Sanberg, P. R.; Morgan, M. B. Human cord blood cells and myocardial infarction: Effect of dose and route of administration on infarct size. Cell Transplant. 16:907–917; 2007.
9. Hoefer, I. E.; Grundmann, S.; van Royen, N.; Voskuil, M.; Schirmer, S. H.; Ulusans, S.; Bode, C.; Buschmann, I. R.; Piek, J. J. Leukocyte subpopulations and arteriogenesis: Specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181:285–293; 2005.
10. Hossne, N. A., Jr.; Invitti, A. L.; Buffolo, E.; Azevedo, S.; Oliveira, J. S. R.; Stolf, N. A. G.; Cruz, E.; Sanberg, P. R. Refractory Angina Cell Therapy (ReACT) involving autologous bone marrow cells in patients without left ventricular dysfunction: A possible role for monocytes. Cell Transplant. 18(12):1299–310; 2009.
11. Jolicoeur, E. M.; Granger, C. B.; Henry, T. D.; Holmes, D. J.; Pepine, C. J.; Mark, D.; Chaitman, B. R.; Gersh, B. J.; Ohman, E. M.; Working Group Members. Clinical and research issues regarding chronic advanced coronary artery disease: Part I: Contemporary and emerging therapies. Am. Heart J. 155:418–434; 2008.
12. Klocke, F. J.; Baird, M. G.; Lorell, B. H.; Bateman, T. M.; Messer, J. V.; Berman, D. S.; O’Gara, P. T.; Carabello, B. A.; Russell, Jr., R. O.; Cerqueira, M. D.; Sutton, M. G. S. J.; DeMaria, A. N.; Udelson, J. E.; Kennedy, J. W.; Verani, M. S.; Williams, K. A.; Antman, E. M.; Smith, Jr., S. C.; Alpert, J. S.; Gregoratos, G.; Anderson, J. L.; Hiratzka, L. F.; Faxon, D. P.; Hunt, S. A.; Fuster, V.; Jacobs, A. K.; Gibbons, R. J.; Russell, R. O. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging – Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108:1404–1418; 2003.
13. Kones, R. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc. Health Risk Manag. 6:749–774; 2010.
14. Kusumanto, Y. H.; Dam, W. A.; Hospers, G. A. P.; Meijer, C.; Mulder, N. H. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283– 287; 2003.
15. Lang, R. M.; Bierig, M.; Devereux Flachskampf, F. A.; Foster, E.; Pellikka, P. A.; Picard, M. H.; Roman, M. J.; Seward, J.; Shanewise, J. S.; Solomon, S. D.; Spencer, K. T.; Sutton, M. S. J., Stewart, W. J. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18:1440–1463; 2005.
16. Leon, M. B.; Kornowski, R.; Downey, W. E.; Weisz, G.; Baim, D. S.; Bonow, R. O.; Hendel, R. C.; Cohen, D. J.; Gervino, E.; Laham, R.; Lembo, N. J.; Moses, J. W.; Kuntz, R. E. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J. Am. Coll. Cardiol. 46:1812–1819; 2005.
17. Losordo, D. W.; Henry, T. D.; Davidson, C.; Sup Lee, J.; Costa, M. A.; Bass, T.; Mendelsohn, F.; Fortuin, F. D.; Pepine, C. J.; Traverse, J. H.; Amrani, D.; Ewenstein, B. M.; Riedel, N.; Story, K.; Barker, K.; Povsic, T. J.; Harrington, R. A.; Schatz, R. A.; ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ. Res. 109(4):428–436; 2011.
18. Losordo, D. W.; Renault, M. A. Therapeutic myocardial angiogenesis. Microvasc. Res. 74:159–171; 2007.
19. Losordo, D. W.; Schatz, R. A.; White, C. J.; Udelson, J. E.; Veereshwarayya, V.; Durgin, M.; Poh, K. K.; Weinstein, R.; Kearney, M.; Chaudhry, M.; Burg, A.; Eaton, L.; Heyd, L.; Thorne, T.; Shturman, L.; Hoffmeister, P.; Story, K.; Zak, V.; Dowling, D.; Traverse, J. H.; Olson, R. E.; Flanagan, J.; Sodano, D.; Murayama, T.; Kawamoto, A.; Kusano, K. F.; Wollins, J.; Welt, F.; Shah, P.; Soukas, P.; Asahara, T.; Henry, T. D. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/ IIa double-blind, randomized controlled trial. Circulation 115:3165–3172; 2007.
20. Mannheimer, C.; Camici, P.; Chester, M. R.; Collins, A.; DeJongste, M.; Eliasson, T.; Follath, F.; Hellemans, I.; Herlitz, J.; Lüscher, T.; Pasic, M.; Thelle, D. The problem of chronic refractory angina. Report from de ESC joint study group on the treatment of refractory angina. Eur. Heart J. 23:355–370; 2002.
21. Moore, R. K.; Groves, D.; Bateson, S.; Barlow, P.; Hammond, C.; Leach, A. A.; Chester, M. R. Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program. Eur. J. Pain 9:305–310; 2005.
22. Mukherjee, D.; Bhatt, D.; Roe, M. T.; Patel; M. T.; Ellis, S. G. Direct myocardial revascularization and angiogenesis: How many patients might be eligible? Am. J. Cardiol. 84:598–600; 1999.
23. Nasseri, B. A.; Kukucka, M.; Dandel, M.; Knosalla, C.; Potapov, E.; Lehmkuhl, H. B.; Meyer, R.; Ebell, W.; Stamm, C.; Hetzer, R. Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy. Cell Transplant. 16(9):941–949; 2007.
24. Perin, E. C.; Dohmann, H. F.; Borojevic, R.; Silva, S. A.; Sousa, A. L.; Mesquita, C. T.; Rossi, M. I.; Carvalho, A. C.; Dutra, H. S.; Dohmann, H. J.; Silva, G. V.; Belém, L.; Vivacqua, R.; Rangel, F. O.; Esporcatte, R.; Geng, Y. J.; Vaughn, W. K.; Assad, J. A.; Mesquita, E. T.; Willerson, J. T. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294–2302; 2003.
25. Perin, E. C.; Willerson, J. T. CD 34+ autologous human stem cells in treating refractory angina. Circ. Res. 109(4):428– 436; 2011.
26. Rana, J. S.; Mannam, A.; Donnell-Fink, L.; Gervino, E. V.; Sellke, F. W.; Laham, R. J. Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am. J. Cardiol. 95:1456–1459; 2005.
27. Roger, V. L.; Go, A. S.; Lloyd-Jones, D. M.; Adams, R. J.; Berry, J. D.; Brown, T. M.; Carnethon, M. R.; Dai, S.; de Simone, G.; Ford, E. S.; Fox, C. S.; Fullerton, H. J.; Gillespie, C.; Greenlund, K. J.; Hailpern, S. M.; Heit, J. A.; Ho, P. M.; Howard, V. J.; Kissela, B. M.; Kittner, S. J.; Lackland, D. T.; Lichtman, J. H.; Lisabeth, L. D.; Makuc, D. M.; Marcus, G. M.; Marelli, A.; Matchar, D. B.; McDermott, M. M.; Meigs, J. B.; Moy, C. S.; Mozaffarian, D.; Mussolino, M. E.; Nichol, G.; Paynter, N. P.; Rosamond, W. D.; Sorlie, P. D.; Stafford, R. S.; Turan, T. N.; Turner, M. B.; Wong, N. D.; Wylie-Rosett, J.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 123:e18–e209; 2011.
28. Sanberg, P. R.; Park, D. H.; Kuzmin-Nichols, N.; Cruz, E.; Hossne, N. A., Jr.; Buffolo, E.; Willing, A. E. Monocyte transplantation for neural and cardiovascular ischemia repair. J. Cell. Mol. Med. 14(3):553–563; 2010.
29. Silva, S. A.; Sousa, A. L.; Haddad, A. F.; Azevedo, J. C.; Soares, V. E.; Peixoto, C. M.; Soares, A. J.; Issa, A. F.; Felipe, L. R.; Branco, R. V.; Addad, J. A.; Moreira, R. C.; Tuche, F. A.; Mesquita, C. T.; Drumond, C. C.; Junior, A. O.; Rochitte, C. E.; Luz, J. H.; Rabischoffisky, A.; Nogueira, F. B.; Vieira, R. B.; Junior, H. S.; Borojevic, R.; Dohmann, H. F. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: Comparison of two delivery techniques. Cell Transplant. 18(3):343–352; 2009.
30. Tse, H. F.; Kwong, Y. L.; Chan, J. K.; Lo, G.; Ho, C. L.; Lau, C. P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cells implantation. Lancet 361:47–49; 2003.
31. Vanderheyden, M.; Vercauteren, S.; Mansour, S.; Delrue, L.; Vandekerckhove, B.; Heyndrickx, G. R.; Van Haute, I.; De Bruyne, B.; Timmermans, F.; Wijns, W.; Bartunek, J. Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant. 16(9):919–925; 2007.
32. van Ramshorst, J.; Bax, J. J.; Beeres, S. L.; Dibbets-Schneider, P.; Roes, S. D.; Stokkel, M. P.; de Roos, A.; Fibbe, W. E.; Zwaginga, J. J.; Boersma, E.; Schalij, M. J.; Atsma, D. E. Inramyocardial bone marrow cell injection for chronic myocardial ischemia. A randomized controlled trial. JAMA 301:1997–2004; 2009.
33. Yerebakan, C.; Kaminski, A.; Liebold, A.; Steinhoff, G. Safety of intramyocardial stem cell therapy for the ischemic myocardium: Results of the Rostock trial after 5-year follow-up. Cell Transplant. 16(9):935–940; 2007.